SRTA
Strata Critical Medical, Inc.
SRTA lost money over the past year, so it has no meaningful PE right now. Analysts expect earnings to recover and profitability to improve.
SRTA Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Under pressure | |
| Stable | |
| Strong |
SRTA's revenue and balance sheet are currently healthy, and its cash flow is stable, but its profitability is under pressure.
SRTA PE Valuation
SRTA has no meaningful PE right now: it lost money over the past year. If it returns to profit as analysts expect, today's price would be 100x next year's earnings.
SRTA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect SRTA to return to profit, with revenue growing.
SRTA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.06 | — |
| Q3 2026 | -$0.29 | -158% |
| Q2 2026 | $0.50 | +$0.73 |
| Q1 2026 | $0.57 | +$0.90 |
| Q4 2025 | $0.50 | +$0.85 |
| Q3 2025 | $0.50 | +$1.19 |
| Q2 2025 | -$0.23 | +$0.43 |
| Q1 2025 | -$0.33 | +$0.35 |
| Q4 2024 | -$0.35 | +$0.41 |
SRTA has swung to a loss: it lost $0.29 per share over the past year, after a profit the year before.
SRTA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $74.1M | +50% |
| Q2 2026 | $72.5M | +2.4% |
| Q1 2026 | $67.4M | +24% |
| Q4 2025 | $66.8M | +23% |
| Q3 2025 | $49.3M | -34% |
| Q2 2025 | $70.8M | +4.2% |
| Q1 2025 | $54.3M | +5.4% |
| Q4 2024 | $54.4M | +14% |
SRTA's revenue has grown year over year for four quarters in a row: $74M last quarter, up 50% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -5.2% | +6.2 points |
| Q2 2026 | -7.5% | -0.5 points |
| Q1 2026 | -4.4% | +9.6 points |
| Q4 2025 | -9.6% | +5.8 points |
| Q3 2025 | -11% | -6.7 points |
| Q2 2025 | -7% | +11 points |
| Q1 2025 | -14% | +5.2 points |
| Q4 2024 | -15% | +60 points |
SRTA's operating margin was −5.2% last quarter, up 6.2 points from the same quarter a year ago.
SRTA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $9.1M | +$49.2M |
| Q2 2026 | $3.2M | +$8.6M |
| Q1 2026 | -$1.3M | +$1.6M |
| Q4 2025 | -$10.2M | -$3.8M |
| Q3 2025 | -$40.1M | -$37.2M |
| Q2 2025 | -$5.4M | +$2.4M |
| Q1 2025 | -$2.9M | +$13.5M |
| Q4 2024 | -$6.3M | +$3M |
SRTA's free cash flow has turned positive after six years mostly in the red: $806,000 over the past year.
SRTA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +2.4% | +2.1M shares |
| 1 year | +7.1% | +5.8M shares |
| 3 years | +9% | +7.3M shares |
| 5 years | +71% | +36.7M shares |
| Available history | +977% | +80.1M shares |
SRTA has 88M diluted shares, up 7.1% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2025 | — |
| Q3 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q4 2019 | — |
SRTA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -10.7x | Net Cash |
SRTA has more cash than debt.
SRTA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.4 | Neutral |
| Stochastic | 49.4 | Neutral |
SRTA's weekly RSI is 57 (neutral) and its Stochastic is 49 (neutral).
SRTA PE vs Industrials Sector
| Metric | SRTA | Sector median | Relative |
|---|---|---|---|
| PE | 8.9x | 24x | 63% below |
| PE % | 20 | 58 | 38 pts below |
SRTA has no meaningful PE right now: it lost money over the past year.
SRTA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $4.95 | 17% above |
| 20 week MA | $5.25 | 9.9% above |
| 50 week MA | $5.11 | 13% above |
| 100 week MA | $4.53 | 27% above |
| 200 week MA | $3.94 | 46% above |
SRTA is in an uptrend: it's above all five of its weekly moving averages, and 46% above its 200-week average.
SRTA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.83 | $11.0 | +12% |
| 2021 | $11.0 | $9.25 | -16% |
| 2022 | $9.25 | $3.50 | -62% |
| 2023 | $3.50 | $3.53 | +0.9% |
| 2024 | $3.53 | $4.41 | +25% |
| 2025 | $4.41 | $4.87 | +10% |
| 2026 YTD | $4.87 | $5.77 | +18% |
SRTA has finished higher in four of the last six years. It's up 18% so far in 2026.